Cargando…
Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls
OBJECTIVES: We wanted to estimate the magnitude of the risk from all-cause, cause-specific and sex-specific mortality in patients with SLE and relative risks compared with matched controls and to evaluate the influence of exposure to medication on risk of mortality in SLE. METHODS: We conducted a po...
Autores principales: | Bultink, Irene E M, de Vries, Frank, van Vollenhoven, Ronald F, Lalmohamed, Arief |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312724/ https://www.ncbi.nlm.nih.gov/pubmed/32653901 http://dx.doi.org/10.1093/rheumatology/keaa267 |
Ejemplares similares
-
Systemic lupus erythematosus and fractures
por: Bultink, Irene E M, et al.
Publicado: (2015) -
Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence
por: Osmani, Zgjim, et al.
Publicado: (2021) -
Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus
por: Bultink, Irene E. M.
Publicado: (2017) -
New developments in systemic lupus erythematosus
por: Tsang-A-Sjoe, Michel W. P., et al.
Publicado: (2021) -
Prospective cohort studies on risk factors for cardiovascular events in systemic lupus erythematosus: a major challenge
por: Bultink, Irene EM
Publicado: (2010)